SMS PHARMA share price has zoomed 3% and is presently trading at Rs 312.5.
Meanwhile, the BSE HEALTHCARE index is at 40,729.9 (up 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are GSK Pharma (up 2.4%) and GRANULES INDIA (up 2.1%).
Jubilant Pharmova (down 2.1%) and MAX HEALTHCARE INSTITUTE (down 1.5%) are among the top losers today.
Over the last one year, SMS PHARMA has moved up from Rs 118.1 to Rs 312.5, registering a gain of Rs 194.4 (up 164.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,736.5 to 40,729.9, registering a gain of 46.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 124.8%), GSK Pharma (up 101.9%) and SUVEN PHARMACEUTICALS (up 99.8%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,204.2 (down 0.8%).
The top losers among the BSE Sensex today are Tata Motors (down 3.9%) and Maruti Suzuki (down 3.6%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,803.7 (down 0.8%). Tata Motors and Maruti Suzuki are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,527.7 to 81,204.2, registering a gain of 14,676.5 points (up 22.1%).
SMS PHARMA net profit grew 99.0% YoY to Rs 161 million for the quarter ended March 2024, compared to a profit of Rs 81 million a year ago. Net sales rose 64.5% to Rs 2,458 million during the period as against Rs 1,494 million in January-March 2023.
For the year ended March 2023, SMS PHARMA reported 94.3% decrease in net profit to Rs 39 million compared to net profit of Rs 679 million during FY22. Revenue of the company grew 1.2% to Rs 4,914 million during FY23.
The current Price to earnings ratio of SMS PHARMA, based on rolling 12 month earnings, stands at 53.8.
Equitymaster requests your view! Post a comment on "SMS PHARMA Gains 3%; BSE HEALTHCARE Index Up 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!